Marie-pierre Podgorniak
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discoidin domain receptors: A promising target in melanoma.
Journal: Pigment cell & melanoma research
Published: February 23, 2018
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor.
Journal: ESMO open
Published: January 31, 2017
Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma.
Journal: Oncotarget
Published: November 26, 2016
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Journal: Experimental dermatology
Published: March 30, 2016
Validation of a preclinical model for assessment of drug efficacy in melanoma.
Journal: Oncotarget
Published: September 07, 2015
EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.
Journal: Experimental dermatology
Published: March 16, 2015
A novel tumor suppressor function of Kindlin-3 in solid cancer.
Journal: Oncotarget
Published: October 27, 2014
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.
Journal: Oncotarget
Published: July 21, 2014
BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.
Journal: Melanoma research
Published: June 17, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026